PHQ-9 results need clinical context, not just a score
The PHQ-9 gives clinicians a structured way to document depressive symptom severity, but the score is only one part of the clinical picture. A useful note connects the score to the client’s reported symptoms, observed presentation, risk follow-up when indicated, treatment goals, and clinical plan.
For therapists, counselors, social workers, psychologists, psychiatrists, and other behavioral health professionals, the PHQ-9 often appears in intake paperwork, ongoing measurement-based care, treatment plan reviews, and payer-related quality workflows. The documentation challenge is making the result clinically meaningful without overstating what the tool can prove.
The PHQ-9 is a nine-item patient questionnaire based on depressive symptoms over the prior two weeks. It has been studied as a brief measure of depression severity and has evidence supporting its validity in clinical settings [source:1]. The American Psychological Association describes the PHQ-9 as a tool used to screen for depression, monitor symptom severity, and track changes over time [source:2].
What the PHQ-9 measures
The PHQ-9 asks about nine symptom areas commonly associated with depression, including mood, interest or pleasure, sleep, energy, appetite, self-perception, concentration, psychomotor changes, and thoughts of self-harm or being better off dead. The client rates how often each symptom has occurred during the past two weeks [source:2].
Responses are typically scored from 0 to 3 for each item, creating a total score range of 0 to 27. Higher scores are associated with greater reported depressive symptom severity. The University of Washington AIMS Center lists common PHQ-9 severity categories as follows: 0–4 minimal, 5–9 mild, 10–14 moderate, 15–19 moderately severe, and 20–27 severe [source:3].
Those categories can help organize documentation, but they should not replace assessment. A client with a lower score may still report functional impairment, grief, trauma-related symptoms, substance use concerns, or safety issues. A client with a higher score may need additional assessment before the clinician determines diagnosis, level of care, or treatment changes.
The PHQ-9 also includes an item related to thoughts of death or self-harm. A positive response to that item generally warrants additional clinical follow-up based on the provider’s scope, setting, risk assessment process, and applicable policies. The PHQ-9 score alone should not be treated as a suicide risk assessment.
When clinicians commonly use the PHQ-9
Behavioral health clinicians may use the PHQ-9 at several points in care. At intake, it can provide a baseline snapshot of depressive symptoms. During ongoing treatment, repeated scores can help the clinician and client discuss changes in symptom burden, functioning, and treatment response.
The U.S. Preventive Services Task Force recommends screening adults for depression, including pregnant and postpartum persons, in systems that can support accurate diagnosis, treatment, and follow-up [source:5]. In mental health practice, that follow-up may include further assessment, treatment planning, referral, medication evaluation, safety planning, or coordination with another provider, depending on the case.
Common use cases include:
- Intake assessment: documenting baseline depressive symptoms and functional concerns.
- Treatment plan updates: comparing current symptoms to earlier presentation and goals.
- Ongoing therapy sessions: discussing symptom movement and client response to interventions.
- Quality measure workflows: recording screening and follow-up activity when required by the clinical setting or payer.
The Centers for Medicare & Medicaid Services electronic clinical quality measure for depression screening addresses documentation of screening and a follow-up plan when the screen is positive [source:8]. Requirements vary by setting, payer, and reporting program, so clinicians should follow their organization’s documentation policies.
How PHQ-9 results can inform therapy documentation
A strong progress note does more than list “PHQ-9 = 14.” It explains how the result fits the session. For example, if the client reports increased sleep disturbance, low motivation, and missed workdays, the score may support documentation of current symptom severity and functional impairment.
In a SOAP note, the PHQ-9 may appear in the Objective or Assessment section, depending on the clinician’s documentation style. In a DAP note, it often belongs in the Data or Assessment section. The plan should describe clinically appropriate next steps, not simply state that the score was reviewed.
Useful documentation elements may include:
- Date administered or reviewed: so later scores can be compared accurately.
- Total score and severity range: if scoring was completed outside the note workflow.
- Relevant item-level concerns: especially sleep, appetite, concentration, impairment, or self-harm item follow-up.
- Client response: how the client understood, agreed with, questioned, or contextualized the result.
After those details, connect the assessment to care. This might include a revised treatment goal, continued behavioral activation work, coordination with a prescriber, additional risk assessment, or monitoring at a future session.
Documentation example for a PHQ-9 result
The example below shows one way to document assessment-related details without claiming the PHQ-9 alone establishes a diagnosis.
Example: Client completed PHQ-9 prior to session with total score of 16, consistent with moderately severe reported depressive symptoms per PHQ-9 severity ranges. Client endorsed low mood, reduced interest, fatigue, sleep disruption, and difficulty concentrating over the past two weeks. Client stated the score “fits how the last two weeks have felt” and described missing two days of work due to low motivation and poor sleep. Clinician reviewed item related to self-harm; client denied current intent, plan, or preparatory behavior during follow-up discussion. Session focused on behavioral activation, identifying one manageable daily activity, and reviewing supports. Plan is to continue monitoring depressive symptoms, revisit sleep routine next session, and coordinate with prescribing provider if symptoms persist or worsen.
This type of entry gives a reviewer more than a number. It records the score, time frame, client response, functional impact, risk follow-up, intervention focus, and next steps. It also avoids saying the PHQ-9 “proved” a diagnosis or that a single score determined treatment.
Common PHQ-9 documentation mistakes
Many PHQ-9 documentation problems come from either under-documenting the result or overstating it. Both can create confusion later, especially when reviewing progress across several months of care.
Recording the score without the clinical meaning
A note that says “PHQ-9 completed, score 18” leaves several questions unanswered. Did the clinician review the result? Did the client agree that it reflected recent symptoms? Was there any self-harm item endorsement? Did the result affect the treatment plan?
Treating the PHQ-9 as a standalone diagnosis
The PHQ-9 can support screening and severity monitoring, but diagnosis requires clinical evaluation. Depression screening resources from MedlinePlus describe screening as a way to help identify symptoms and determine whether further evaluation is needed [source:4]. A careful note might state that the score is “consistent with” a severity range or “supports continued assessment,” rather than saying the score alone confirms major depressive disorder.
Ignoring functional impact
Depressive symptoms matter clinically because they affect daily life. Documentation is stronger when it connects symptoms to work, school, caregiving, hygiene, relationships, sleep, appetite, or treatment engagement. “Client reports fatigue” is less useful than “Client reports fatigue contributing to missed morning classes twice this week.”
Missing follow-up on item 9
If the self-harm-related item is endorsed, the note should reflect clinically appropriate follow-up. That may include clarifying intent, plan, means, protective factors, prior behavior, current supports, crisis resources, safety planning, consultation, or referral, depending on the client’s presentation and the clinician’s role.
How to document without overstating conclusions
Precise language protects clinical accuracy. The PHQ-9 is useful because it creates a repeatable structure, but client reports, clinician observation, history, differential diagnosis, culture, medical conditions, substance use, trauma, grief, and current stressors may all affect interpretation.
Use wording that reflects the limits of the measure:
- “PHQ-9 score of 11 falls in the moderate range of reported depressive symptoms.”
- “Score increased from 8 to 13 since last administration; client attributes increase to job loss and reduced sleep.”
- “Results reviewed with client and incorporated into treatment plan update.”
- “PHQ-9 result supports further assessment of depressive symptoms and functional impairment.”
Avoid phrasing such as “PHQ-9 diagnosed depression,” “client is severely depressed based only on PHQ-9,” or “score confirms suicide risk.” Those statements go beyond what the tool can establish by itself.
Where the PHQ-9 fits in SOAP and DAP notes
Clinicians document assessment tools in different note formats. The best placement depends on the structure required by the practice, EHR, payer, or agency. The key is consistency.
SOAP note placement
In a SOAP note, the client’s description of symptoms may appear under Subjective. The PHQ-9 score may fit under Objective if the clinician treats it as a measurement result, or under Assessment if the note emphasizes clinical meaning. The Plan should address follow-up, monitoring, interventions, referrals, or coordination of care.
DAP note placement
In a DAP note, the Data section may include the score, reported symptoms, and client statements. The Assessment section can describe how the score relates to symptom severity, risk, functioning, and treatment progress. The Plan section should identify next steps.
For example, a DAP assessment might state: “PHQ-9 score increased from 9 to 14 since prior treatment plan review, suggesting increased reported depressive symptom burden. Client linked change to recent separation and reduced sleep. No current suicidal intent or plan reported during follow-up assessment.”
How AutoNotes supports PHQ-9-related documentation
AutoNotes helps clinicians create structured, editable progress note drafts from session details. For PHQ-9-related documentation, that means the clinician can include the score, client comments, symptom context, risk follow-up, interventions, and plan details, then use AutoNotes to organize those details into a clearer note draft.
AutoNotes does not need to replace the clinician’s assessment process. The clinician remains responsible for administering tools when appropriate, scoring assessments, interpreting results within scope, completing any required risk assessment, and finalizing the clinical record.
Where AutoNotes can help is the documentation step after the clinical work has occurred. For example, a therapist can enter or dictate session details such as: “PHQ-9 score 12, reviewed with client, sleep worse, no self-harm intent, practiced activity scheduling, plan to monitor mood next week.” AutoNotes can help turn those details into an organized draft using a therapy note format selected by the clinician.
This can reduce the time spent rebuilding the same documentation structure after each session. It can also support consistency across notes by prompting clinicians to capture details that are easy to forget after a full day of appointments: client response, progress toward goals, intervention used, and next step.
Practical PHQ-9 note checklist
Before finalizing a note that references the PHQ-9, review whether the entry includes the clinical details another provider, supervisor, auditor, or future version of you would need.
- Was the total score and date documented?
- Was the severity range described accurately, if included?
- Was client response or context recorded?
- Was follow-up documented for any self-harm-related endorsement?
Also check that the plan matches the clinical picture. If the score changed significantly, the note should usually explain what changed, what the client reported, and how treatment will respond. If the score stayed the same but functioning improved, document that nuance.
Build cleaner assessment notes with clinician-controlled AI drafts
The PHQ-9 can add structure to depression screening, symptom monitoring, and treatment planning, but the quality of the note depends on the clinician’s context and judgment. The strongest documentation connects the score to symptoms, functioning, client response, risk follow-up when indicated, and next steps.
AutoNotes gives behavioral health professionals a faster way to draft structured notes while keeping review and final edits in the clinician’s hands. If PHQ-9 results are part of your documentation workflow, AutoNotes can help organize those details into consistent SOAP, DAP, intake, assessment, or treatment planning drafts.
Start your free trial and see how AutoNotes can help you create clearer, editable clinical note drafts with less after-hours writing.
References
- [source:1] The PHQ-9: Validity of a Brief Depression Severity Measure – PubMed
- [source:2] Patient Health Questionnaire (PHQ-9 & PHQ-2) – American Psychological Association
- [source:3] PHQ-9 Depression Scale – University of Washington AIMS Center
- [source:4] Depression Screening – MedlinePlus / National Library of Medicine
- [source:5] Depression and Suicide Risk in Adults: Screening – U.S. Preventive Services Task Force
- [source:8] Screening for Depression and Follow-Up Plan – eCQI Resource Center / CMS
